Lipoedema & The Venn Diagram of Multi-System Dysregulation

When Apparently Unrelated Symptoms Start to Look Related

After repeated visits to the GP for seemingly unrelated symptoms, eventually the doctor starts realising that too many body systems are involved for everything to keep being treated as separate isolated problems.

Irritable Bowel Syndrome
Migraine
Exhaustion/ Fatigue
Food intolerances
Eczema
Palpitations
Dizziness
Interstitial cystitis
Chronic pain

For years, each symptom may have been approached and treated individually. Bowel symptoms sit in one box. Migraine in another. Skin reactions somewhere else. Fatigue, palpitations or dizziness somewhere else again.

Eventually, the GP joins the dots.

That is often where Mast Cell Activation Syndrome (MCAS) enters the picture.

When MCAS Brings Symptoms Under One Umbrella

Part of the reason MCAS has gained so much attention recently is that it brings apparently unrelated symptoms into a single framework. Instead of viewing migraines, IBS, skin reactions, fatigue or palpitations as isolated problems affecting entirely separate systems, MCAS starts connecting them through mast cell activation, histamine release and inflammatory signalling.

For most patients, that can feel like the first time the overall picture has made sense.

The Expanding Venn Diagram of Dysregulation

What makes the subject particularly interesting is that MCAS itself often does not remain the endpoint either. Once MCAS is recognised and acknowledged, the discussion frequently widens into broader patterns of bodywide, multisystem dysfunction.

  • Autonomic dysregulation.
  • Inflammatory dysregulation.
  • Immune dysregulation.
  • Nervous system sensitisation.
  • Connective tissue dysfunction.

The conditions and causes begin overlapping.

What may have started as several apparently unrelated symptoms gradually becomes interpreted as part of a larger multisystem pattern.

Where Lipoedema Starts Appearing Within the Overlap

Conceptual illustration of multi-system dysregulation showing overlapping translucent Venn diagram circles surrounding a female anatomical figure, representing the overlap between MCAS, lipoedema, inflammation, nervous system sensitisation, immune dysregulation and connective tissue dysfunction.

Many women with lipoedema describe histories involving migraine, IBS, fatigue, chronic pain, hypermobility, autonomic symptoms or inflammatory skin reactions, with MCAS increasingly appearing somewhere within that wider picture too.

From my perspective, lipoedema is still largely spoken about as a collection of symptoms and physical characteristics rather than a fully understood disease process.

We recognise:

• Disproportion
• Pain
• Inflammation
• Tissue changes
• Nodularity
• Bruising
• Hormonal relationship

But we still do not fully understand the underlying cause.

And until underlying mechanisms are better understood, treatment inevitably remains focused largely on symptom management rather than targeting root cause.

What becomes particularly interesting is when multiple overlapping symptoms and conditions start appearing repeatedly within the same individuals.

• Silent Migraines
• IBS
• Endometriosis / gynaecological symptoms
• Hernias / prolapses / miscarriages
• Autonomic symptoms
• Chronic pain / fibromyalgia
Hypermobility / Ehlers-Danlos syndrome
• Fatigue
POTS
MCAS

At that point, an important question begins emerging.

Are these genuinely separate unrelated conditions simply co-existing alongside one another?

Or are they different manifestations of a broader process involving bodywide multi-system dysregulation?

Lipoedema itself already demonstrates dysregulation at tissue level. Adipose tissue behaves differently from unaffected fat, with disproportionate deposition, inflammatory change and extensive biological differences identified within the tissue environment.

Increasingly, it becomes difficult to ignore the possibility that many of these overlapping symptoms may not exist entirely independently from one another at all.

That does not mean all women have the same conditions, or that one single mechanism explains every symptom.

But it does increasingly challenge the idea that chronic multisystem symptoms should always be viewed in isolation from one another.

Perhaps the most significant shift is not the emergence of any single label, but the growing recognition that many women do not fit neatly within traditional diagnostic boundaries at all.

The circles seem to overlap and increasingly, the dysregulation no longer appears confined to one system alone.